Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukine in Biochemically-relapsed Prostate Cancer
NCT00908141Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jun 2006
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in prostate cancer (PCa), sponsored by Case Comprehensive Cancer Center. Started Jun 2006; status: completed.
02
Drugs
sargramostim
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00908141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908141.